Cargando…
Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19
Autores principales: | De Wilton, Angus, Nabarro, Laura E., Godbole, Gauri S., Chiodini, Peter L., Boyd, Aileen, Woods, Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847532/ https://www.ncbi.nlm.nih.gov/pubmed/33535106 http://dx.doi.org/10.1016/j.tmaid.2021.101981 |
Ejemplares similares
-
Strongyloides stercoralis Hyperinfection Syndrome in Pregnancy
por: Akers, Allison N, et al.
Publicado: (2023) -
Dexamethasone/ivermectin: Paradoxical dissemination of Strongyloides stercoralis infection, Strongyloides hyperinfection syndrome and treatment failure: case report
Publicado: (2021) -
Fatal Strongyloides Hyperinfection Syndrome in an Immunocompromised Patient
por: Pochineni, Vaishnavi, et al.
Publicado: (2015) -
Strongyloides Hyperinfection Syndrome Combined with Cytomegalovirus Infection
por: Elzein, Fatehi Elnour, et al.
Publicado: (2016) -
Strongyloides stercoralis hyperinfection syndrome with cerebral involvement
por: Pedersen, Andreas Arnholdt, et al.
Publicado: (2022)